Amgen wins US patent battle on arthritis drug, thwarting Novartis – MENAFN.COM

Amgen wins US patent battle on arthritis drug, thwarting Novartis  MENAFN.COM

(MENAFN – Gulf Times) A US judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying a chall.